Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#619 Diagnostic Accuracy of F-18-DOPA PET or PET/CT in Neuroendocrine Tumors: A Meta-Analysis

Introduction: A specific feature of NETs is amine precursor uptake and decarboxylation; this is the rationale for using PET with F-18-DOPA, a cathecholamine precursor, in diagnosis of NETs.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Treglia G

Authors: Muoio B, Treglia G, Rufini V,

Keywords: PET, PET/CT, F-18-DOPA, neuroendocrine tumors,

#589 Pancreatic neuroendocrine tumors and Diffusion weighted MRI: a better tool for detection?

Introduction: Pancreatic neuroendocrine tumors (pNETs) are often difficult to detect because of small size. Because surgery is curative in localized pNETs, preoperative localization is necessary.

Conference:

Presenting Author:

Authors: Farchione A, Brizi M, Treglia G, Massara R, Stefanelli A,

Keywords: MRI, DWI, pancreatic-neuroendocrine-tumors, PET.,

#580 Diagnostic Performance of Dual Tracer PET/CT in Staging Neuroendocrine Tumors of the Lung

Introduction: Different positron emission tomography/computed tomography (PET/CT) tracers may be useful in staging lung neuroendocrine tumors (LNETs)

Conference:

Presenting Author:

Authors: Treglia G, Stefanelli A, Cardillo G, Lococo F, Rindi G,

Keywords: Neuroendocrine tumors, lung carcinoids, PET/CT,

#484 Diagnostic Accuracy of Gallium-68 Somatostatin Receptor Positron Emission Tomography in Patients with Thoracic and Gastroenteropancreatic Neuroendocrine Tumors: A Meta-Analysis

Introduction: Gallium-68 somatostatin receptor (SMSR) positron emission tomography (PET) is a valuable diagnostic tool for patients with neuroendocrine tumors (NET). To date, a meta-analysis about the diagnostic accuracy of this functional imaging method is lacking.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Treglia G, Rufini V, Castaldi P, Muoio B, Giordano A,

Keywords: PET, Gallium-68, neuroendocrine tumors,

#351 Comparison of 68Ga-Somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma

Introduction: Early detection of recurrences is a crucial step in the management of patients (pts) with medullary thyroid carcinoma (MTC). Currently, there is growing interest for PET tracers in MTC such as: 18F-FDG (reflecting glucose metabolism), 18F-DOPA (reflecting amine decarboxylation), 68Ga-somatostatin analogues (reflecting somatostatin receptors expression)

Conference:

Presenting Author:

Authors: Treglia G, Castaldi P, Villani M, Filice A, Ambrosini V,

Keywords: PET/CT; medullary thyroid carcinoma; recurrence diagnosis.,